Alexander Izaguirre, Chief Data Officer, New York City Health and Hospitals
Alex serves as the Chief Data Officer of New York City’s Health and Hospitals corporation (NYC H+H), the largest public health system in the United States. He is responsible for developing a comprehensive data and analytics program aimed at helping the system make better data informed decisions and with an amazing team of data professionals led targeted and rapid development of solutions to support situational awareness, clinical operations and resource/staff planning for the COVID-19 pandemic.
Prior to joining NYC H+H in May of 2019, Alex served as an executive partner with Gartner Research, advising over 30 CIOs and information technology leaders in the health care space on how to best leverage technologies to; improve operational efficiencies, generate, and utilize data and develop digital solutions.
Alex’s strong professional brand at Gartner was due to his strong commitment to service as well as his health care technology experience gained by serving as vice president and CIO for Baylor College of Medicine, Houston TX and executive director of IT for the Robert Wood Johnson Medical School at Rutgers University, NJ. Alex also led the research technology effort for the Office of the Senior Associate Dean of Research for New Jersey Medical School. Collectively, Alex has led numerous performance and technology improvement efforts to support the basic sciences, clinical and translational science research, electronic health system implementations and optimizations as well as medical and allied health professions education and LCME accreditation.
Fueled by a general curiosity and persistent interest in solving complex problems, Alex taught himself foundational technology and software programming skills while earning his PhD from Rutgers University. As a researcher, Alex has proved himself an accomplished scientist in the field of viral Immunology. He has been published in a number of journals and was recognized in the 2008 Dolph Adams Award and the State of the Journal of Leukocyte Biology for the most highly cited original research paper in the previous five years.